GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envista Holdings Corp (NYSE:NVST) » Definitions » 5-Year ROIIC %

Envista Holdings (Envista Holdings) 5-Year ROIIC % : -174.38% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Envista Holdings 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Envista Holdings's 5-Year ROIIC % for the quarter that ended in Dec. 2023 was -174.38%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Envista Holdings's 5-Year ROIIC % or its related term are showing as below:

NVST's 5-Year ROIIC % is ranked worse than
91.69% of 806 companies
in the Medical Devices & Instruments industry
Industry Median: 0.26 vs NVST: -174.38

Envista Holdings 5-Year ROIIC % Historical Data

The historical data trend for Envista Holdings's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envista Holdings 5-Year ROIIC % Chart

Envista Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
5-Year ROIIC %
Get a 7-Day Free Trial - - - -8.77 -174.38

Envista Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -174.38 -

Competitive Comparison of Envista Holdings's 5-Year ROIIC %

For the Medical Instruments & Supplies subindustry, Envista Holdings's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Envista Holdings's 5-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Envista Holdings's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Envista Holdings's 5-Year ROIIC % falls into.



Envista Holdings 5-Year ROIIC % Calculation

Envista Holdings's 5-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( 528.91398 (Dec. 2023) - 228.63408 (Dec. 2018) )/( 5445.7 (Dec. 2023) - 5617.9 (Dec. 2018) )
=300.2799/-172.2
=-174.38%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Envista Holdings  (NYSE:NVST) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Envista Holdings 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Envista Holdings's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Envista Holdings (Envista Holdings) Business Description

Traded in Other Exchanges
Address
200 S. Kraemer Boulevard, Building E, Brea, CA, USA, 92821
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.
Executives
Eric Conley officer: SVP, Orthodontics 200 S. KRAEMER BLVD, BLDG E, BREA CA 92821
Mark E Nance officer: Senior Vice President, GC, Sec 1333 S SPECTRUM BLVD #100, CHANDLER AZ 85286
Stephen Keller officer: Principal Financial Officer 200 S. KRAEMER BLVD., BUILDING E, BREA CA 92821
Amir Aghdaei director, officer: PRESIDENT AND CEO C/O CREDENCE SYSTEMS CORPORATION, 1421 CALIFORNIA CIRCLE, MILPITAS CA 95035
Faez C Kaabi officer: Chief Accounting Officer 200 S. KRAEMER BLVD., BUILDING E, BREA CA 92821
Howard H Yu officer: SENIOR VICE PRESIDENT, CFO 250 S. KRAEMER BLVD., BREA CA 92821
Mischa Reis officer: SENIOR VICE PRESIDENT C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD, BLDG. E, BREA CA 92821
Curt W Bludworth officer: SENIOR VICE PRESIDENT, CHRO 250 S. KRAEMER BLVD., BREA CA 92821
Barbara B. Hulit director C/O FORTIVE CORPORATION, 6920 SEAWAY BLVD, EVERETT WA 98203
Jeffrey Kappler officer: SENIOR VICE PRESIDENT C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD, BLDG. E, BREA CA 92821
Teresa Gayle Sheppard director C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD., BLDG. E, BREA CA 92821
Vivek Jain director ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Jean-claude Kyrillos officer: Senior Vice President C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD., BLDG. E, BREA CA 92821
Kieran Gallahue director PO BOX 684369, PARK CITY UT 84068
William K Daniel director 2135 WEST MAPLE ROAD, TROY MI 48084

Envista Holdings (Envista Holdings) Headlines